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Abstract
Background: Burkholderia cepacia is a Gram-negative pathogen that causes serious respiratory infections in
immunocompromised patients and individuals with cystic fibrosis. This bacterium is known to release extracellular
proteins that may be involved in virulence.
Methodology/Principal Findings: In the present study, B. cepacia grown to mid-logarithmic and early-stationary phases
were investigated on their ability to invade and survive intracellularly in A549 lung epithelial cells in order to discern the
fate of these bacteria in the pathogenesis of B. cepacia lung infections in in vitro condition. The early-stationary phase B.
cepacia was demonstrated to be more invasive than mid-logarithmic phase. In addition, culture supernatants of B. cepacia
obtained from these phases of growth were also demonstrated to cause different cytotoxic potency on the A549 human
lung epithelial cells. Profiling of the supernatants using the gel-based proteomics approach identified 43 proteins that
were commonly released in both the growth phases and 40 proteins newly-released at the early-stationary phase. The
latter proteins may account for the higher cytotoxic activity of the early-stationary culture supernatant compared to that
obtained at the mid-logarithmic phase. Among the newly-released proteins in the early-stationary phase supernatant
were flagellar hook-associated domain protein (FliD), flagellar hook-associated protein (FlgK), TonB-dependent
siderophore (Fiu), Elongation factor G (FusA), phosphoglycerate kinase (Pgk) and sulfatase (AslA) which are known for
their virulence.
Conclusion/Significance: Differences in the ability of B. cepacia to invade and survive intracellularly inside the epithelial cells
at different phases of growth may improve our understanding of the varied disease progressions associated with B. cepacia
infections. In addition, the identified culture supernatant proteins may be used as targets for the development of new
strategies to control B. cepacia infection using agents that can block their release.
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Introduction
Burkholderia cepacia complex consists of nine closely related
bacterial species (genomovars) that share some phenotypic or
genotypic similarities. This organism is an opportunistic human
pathogen associated with life-threatening pulmonary infections
that affect immunocompromised individuals particularly patients
with cystic fibrosis (CF) [1] and chronic granulomatous disease [2].
Furthermore, the bacteria have a potential for patient-to-patient
spread and present as a threat for nosocomial acquired infection
[1]. B. cepacia is known to adhere, colonise, invade, replicate,
survive and persist in the host cells, as well as evade the host
immune response [3]. Several researchers have demonstrated that
the bacterial secretory products may play roles in colonisation or
invasion by damaging the epithelial cells [4,5]. In addition, B.
cepacia is also known to produce several secreted products such as
proteases [6], lipases [4], cytotoxins [7] and haemolysins [8] that
are known to exhibit virulence [9] and contribute to severe
inflammatory response that may induce host cell death [10].
B. cepacia secretory proteins play an important role in the
pathogenesis of many infections. They are exposed to the host
immune system and therefore may represent the inter-phase of
bacterium-host interaction [11]. In vitro cultivation of bacteria
results in the accumulation of a complex set of excreted
proteins, collectively termed as the secretory or released proteins
into the extracellular milieu. Many, but not all the secretory
proteins are key virulence factors required for pathogenesis of
infection [1]. Secretory proteins that cause virulence target host
cellular processes including those linked to innate responses, and
to disruption or alteration of pathways [12].
The number and types of proteins released into the culture
supernatant have been demonstrated to be highly dependent
on the cultivation properties and the duration of growth of the
bacteria [13]. Numerous secretory proteins produced by other
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intracellular pathogens such as Mycobacterium tuberculosis [14],
Listeria monocytogens [15] and Helicobacter pylori [16] have been
previously identified by 2-DE and MS analyses. However,
there are many other secretory proteins whose identities,
structures and putative roles that have yet to be elucidated.
Thus, the objective of the present study was to determine the
cytotoxic effect of B. cepacia supernatants collected at the mid-
logarithmic and the early-stationary growth phases and to profile
their protein compositions using the 2-DE-based proteomics
approach. It was aimed to identify proteins that may be involved
in pathogenesis of the disease.
Methods
Ethics statement
Ethics approval is not required in this study. No consent was
required since no human participant was involved. The B. cepacia
strain used in this study is a clinical isolate which was obtained
from the old archive bacterial collection. Since our institute is a
teaching hospital, bacterial isolates obtained as a part of diagnostic
screening are archived and such cases are exempted from
obtaining clearances. The study however has an Institutional
Biosafety Committee approval.
Bacterial strain, growth and culture conditions
The bacterial culture of B. cepacia CQK, isolated from a non-CF
patient at the University Malaya Medical Centre, Malaysia, was
prepared according to protocols earlier described [17]. Fifty ml of
the bacterial culture was inoculated into 13 flasks, each containing
50 ml of fresh LB medium (representing 0 hour to 24 hours at 2-
hourly intervals) and the cultures were grown at 37uC. Bacterial
density at OD600 nm and viable counts [18] were determined for
the respective flasks. Three independent experiments were
conducted for each supernatant sample. Culture sample was
centrifuged at 20,000 g for 40 minutes at 4uC, after which the
supernatant was harvested and filtered through a 0.22 mm pore
size membrane filter to remove residual bacteria [17] The culture
supernatant was concentrated 50-fold using ultrafiltration employ-
ing 10 kDa centricon ultra-free centrifugal filter units (Millipore,
Massachusetts, USA). An isocitrate dehydrogenase assay to
specifically detect bacterial lysis was performed according to
Anderson et al. [13].
Invasion assay
Approximately 56105 A549 cells were seeded into each well of
a 24-well tissue culture plate containing 1 ml of RPMI growth
medium containing 10% foetal calf serum and incubated at 37uC
overnight. When 70–80% confluent monolayer was achieved, the
RPMI growth medium was replaced with RPMI maintenance
medium. The invasion assay was performed as described by
Martin and Mohr (2000) [3] with slight modifications. The A549
cells were infected with B. cepacia grown to mid-logarithmic and
early-stationary phase. The bacterial culture was centrifuged at
300 g for 5 minutes and the resulting pellet was incubated at 37uC
in 1 ml RPMI for 30 minutes. The amount of bacterial inoculum
was standardised to ,16108 cfu/ml. Confluent monolayers of
A549 cells were infected with bacterial inoculum at multiplicity of
infection (MOI) of 1:50. The plates were incubated for 3 hours
respectively, at 37uC in 5% CO2 to allow bacterial adherence and
invasion. After incubation, the monolayers were washed using
100 mM PBS (pH 7.0), after which 3 ml of RMPI containing a
combination of ceftazidime (1 mg/ml) and gentamicin (1 mg/ml)
was added into each well for 2 hours at 37uC to kill extracellular
adherent bacteria. The cell monolayers were then washed three
times with PBS and in addition, the final volume of PBS used to
wash the monolayers was collected and plated on a NA to
determine the number of live extracellular bacteria. The
monolayer cells were then trypsined to detach the cells from the
tissue culture wells and the detached cells lysed with 0.25% Triton
X-100 prepared in PBS to quantitate the intracellular bacteria.
Serial dilutions of the lysate was prepared and plated on NA to
determine the bacterial counts [18]. This experiment was
performed in triplicates and the results were averaged. A non-
invasive strain of Escherichia coli strain, was used as a negative
control
Intracellular survival assay
The A549 epithelial cell monolayers were inoculated with B.
cepacia bacteria harvested at mid-logarithmic and early-stationary
phase at a MOI of 50:1 for 3 hours. Following incubation at 37uC,
the infected monolayers were washed with PBS and tissue culture
medium containing a combination of ceftazidime (1 mg/ml) and
gentamicin (1 mg/ml) was added and incubated for 2 hours to kill
adherent extracellular bacteria. The medium was then replaced
with antibiotic-free RPMI for 3 hours. The infected monolayers
were trypsinised, lysed and the intracellular surviving bacteria
were quantitated by serial dilution and plating over time as
described above [18]. This experiment was repeated three times
and the results were averaged.
Cell viability assay
The culture supernatant harvested at every 2 hours interval was
tested for cytotoxicity against A549 lung epithelial cells which were
purchased from American Type Culture Collection (ATCC,
Virginia, USA). The cells were maintained in RPMI 1640
medium (Sigma Chemical Co., St Louis, USA) supplemented
with 2 mM L-glutamine and 10% FCS (Sigma Chemical Co., St
Louis, USA) at 37uC with 5% CO2 atmosphere and saturating
humidity. Cells were detached using trypsin (Sigma Chemical Co.,
St Louis, USA) and seeded at 26104 cells in each well of a 24-well
cell culture plate, and incubated at 37uC overnight. The cells were
then treated with 50 ml of an initial concentration equivalent to
50 mg/ml from each phase of growth and serially-diluted culture
supernatants in RPMI medium. The treated cell lines were then
incubated at 37uC overnight and the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay to determine cell
toxicity was performed according to the manufacturer’s protocol
(Sigma Chemical Co., St. Louis, USA). Briefly, MTT solution was
added into each well, mixed thoroughly and incubated at 37uC for
4 hours. The media plus MTT solution was then removed and
DMSO added into each well to dissolve the formation of
formazan. The absorbance was measured using a microtitre plate
reader (BioRad, Hercules, USA) at OD570 nm. The experiment
was performed in triplicate and RPMI and LB media were used as
controls.
Two-dimensional gel electrophoresis (2-DE)
Fractions of culture supernatant of B. cepacia mid-logarithmic
and early-stationary phases were subjected to precipitation using
25% (w/v) ice-cold trichloroacetic acid and prepared for 2-DE as
previously described [17]. Protein concentrations were estimated
using Bradford’s method [19]. A total of 400 mg protein sample
with the rehydration buffer (8 M urea, 2% CHAPS, 0.002%
bromophenol blue) was applied onto the IPG strips (pH 4–7,
13 cm; GE Healthcare, Uppsala, Sweden). After 18 hours of
rehydration under mineral oil, the protein was focused using
IPGphor system (GE Healthcare, Uppsala, Sweden) as previously
described [20]. The strips were then transferred onto 12% SDS-
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PAGE [15] for the second dimension electrophoresis. The
resulting gels were stained using colloidal CBB [21]. Three
biological growth experiments were performed to increase
reproducibility of the results. The gels were scanned with an
Image Scanner and analysed using the Image Master TM 2D
Platinum version 5.0 (GE Healthcare, Uppsala, Sweden).
Mass spectrometry (MS) analysis
Selected protein spots were excised from the CBB G-250
stained 2-DE gels and digested with solution of sequencing-grade
modified trypsin (Promega, Madison, USA). The peptides released
from the gel were sent to the Australian Proteome Analysis Facility
(APAF) for further analysis using matrix-assisted laser desorption/
ionization – time of flight mass spectrometry (MALDI-TOF/MS).
Protein identification and in silico analysis
Mass spectrometry data were submitted for database search
using the MASCOT search engine (Matrix Science, London, UK).
The following search settings were used: carboxymidomethylation
of cysteine was the fixed modification; and oxidation of
methionine was selected as the variable modification; maximum
number of missed cleavages - 1; and peptide tolerance – 100 ppm
[17]. All searches were performed against the non-redundant
NCBI library (http://ncbi.nlm.nih.gov) database comprising
annotated proteins of B. cepacia complex (Bcc). Functional class
assignment of the identified proteins based on Cluster of
Orthologous Groups (COG) of proteins functional categories
(http://www.ncbi.nlm.nig.gov/COG/old/palox.cgi?fun=all). The
bioinformatics database (www.cds.dtu.dk) was used to predict the
mode of secretion (SignalP v3.0), cellular localisation (PSORT)
and protein domains (TMHMM v2.0).
Results
Bacterial growth condition
There was a good correlation observed between the optical
density and viable counts of B. cepacia CQK culture at various
phases of growth. The bacterial density increased rapidly from
then on, reaching 1.076107 cfu/ml at 10 hours (early-stationary
phase), with an OD600 nm of 0.495, and 3.92610
9 cfu/ml after
24 hours, with an OD600 nm of 0.477 (Fig. 1). The levels of
isocitrate dehydrogenase, an intracellular enzyme activity which is
used to reflect cell lysis, were found to be insignificant during the
mid-logarithmic and early-stationary phases of bacterial growth.
Invasion of A549 epithelial cells by B. cepacia
The ability of B. cepacia to invade and survive intracellularly in
the epithelial cell was measured and compared between two
different phases of growth (mid-logarithmic and early-stationary
phase) (Table 1). The infected cells were incubated at time
intervals of 3 hours to investigate the capacity of the bacteria to
invade the epithelial cells. The E. coli that was used as a negative
control did not demonstrate capability to invade into the epithelial
cells. In addition, appropriate measures were taken to ensure that
no extracellular bacteria were present before the cells were lysed.
At MOI 1:10, three hours of post-infection, the number of
bacterial cells penetrated into A549 cells were low, with
0.004460.00016% (mid-logarithmic phase) and 0.00886
0.00032% (early-stationary phase). The invasion capacity at an
MOI 1:50 was comparatively higher than at MOI 1:10 at the
different phases of growth. The mean percentage of invasion
increased approximately two-fold at MOI 1:50 post-infection to
0.008960.0016% (mid-logarithmic phase) and 0.015560.0016%
(early-stationary phase). The percentage of invasion was found to
be dependent upon the inoculum size used. The early-stationary
phase bacteria were more invasive at both the MOI of 1:10 and
1:50 than the mid-logarithmic phase. The isolate showed a
variable degree of invasion capacity at different bacterial phases of
growth with different MOI.
Intracellular survival of B. cepacia
The ability of the B. cepacia isolates to enter cultured human
epithelial cells with different invasion frequencies prompted the
examination of intracellular replication rate. The inoculum size and
growth phases used in intracellular survival assay were identical to
invasion assay. The comparison of intracellular survival capacity at
different phases of culture growth (mid-logarithmic, and early-
stationary phase) was indicated as log10 (Fig. 2). The intracellular
survival assays at 3 hours with MOI 1:10 demonstrated that the
number of B. cepacia survived intracellularly increased slightly from
log10 2.37 to log10 2.70 at mid-logarithmic and early-stationary
phase, respectively. However, with MOI 1:50 intracellular replica-
tion, slow replication of B. cepacia in the epithelial cells was
demonstrated, where the number of bacteria was observed to
increase by log10 0.24. Overall, the B. cepacia strain was shown to be
able to survive and replicate slowly intracellularly, however it
depends on the number of bacteria that invaded the A549 cells.
Effect of bacterial culture supernatant on A549 cells
The cytotoxic effect of the bacterial culture supernatants,
harvested at different time-points in the growth cycle of the
bacteria was demonstrated when the supernatants were added to
cultures of A549 cells (Fig. 3). Exposure of the A549 cells to the
culture supernatants obtained at 2 hours, with protein concentra-
tions of 25 and 50 mg/ml, caused 14–32% cell death. Survival was
further reduced by 80–96% when 4 hours to 14 hours culture
supernatants were added to the A549 cell cultures. Only 2–6% of
the A549 cells were found to survive in the presence of 16 hours
and 24 hours culture supernatants of the bacteria.
Profiling of culture supernatant proteins
Figure 4 demonstrates the 2-DE protein profiles of B. cepacia
supernatants harvested from cultures grown at mid-logarithmic
(panel A) and early-stationary (panel B) phases. While 56 protein
spots were detected in the supernatant of cultures collected at the
mid-logarithmic phase, 83 spots were resolved from the early-
stationary phase culture supernatant. Among the protein spots
detected in the supernatant of cultures collected at the mid-
logarithmic phase, 13 were apparently not present in the early-
stationary phase culture supernatant. On the other hand, 40
newly-released spots were detected in the supernatant obtained
from the early-stationary phase bacterial cultures.
Identification of culture supernatant proteins
Out of a total of 96 protein spots detected in the 2-DE profiles,
81 were subsequently identified using MS and database search
(Table S1). The remaining 15 protein spots were of low abundance
and in insufficient quantities for the MALDI-TOF analysis. Upon
identification, several of the protein spots turned up to be isoforms
of the same proteins. For example, DnsK and FliD were
apparently resolved into three different isoforms in the 2-DE gels,
while two isoforms were detected for Eno, AlaDH, TktA, Fiu FusA
and hypothetical protein.
In silico analysis of bacterial released proteins
When analysed using bioinformatics software, three of the
identified proteins that were exclusively detected in the supernatant
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of bacterial culture obtained at the mid-logarithmic phase were
found to be involved in metabolism (i.e., purA, GuaB and TpiA),
while the other three were associated with cellular processes (i.e.,
DnaK (3 isoforms), RfaG and GlmU; Table S2). Among proteins
that were commonly detected in the mid-logarithmic and early-
stationary phase culture supernatants, 21 were apparently involved
in metabolism, 12 with cellular processes and six in information
storage and processing (Fig. S1, panel A). One of the proteins (i.e.,
AdhP) which were commonly detected in the mid-logarithmic and
early-stationary phase culture supernatants could not be char-
acterised. Among proteins detected in the supernatants collected at
mid-logarithmic phase culture, 54.3% were found to be located in
the cytoplasm, 8.7% in the cytoplasmic membrane and 32.6% had
no known location (Fig. S1, panel B). Three proteins, i.e., MetK,
Spr and FtsZ, were apparently associated with multiple locations.
FliD was predicted as an extracellular protein and Fiu as an outer
membrane protein. Among the 35 proteins detected as newly-
released at the early-stationary phase of bacterial growth, 12 were
involved in metabolism, 10 in cellular processes, eight in storage and
processing of information and five were not characterised (Fig. S2,
panel A). Among the proteins released at the early-stationary phase,
40% were predicted to be located at the cytoplasm and another 40%
had no known location; 5.7% in the cytoplasmic membrane; 5.7% in
the outer membrane; and 8.6% were predicted to be the extracellular
secreted proteins (Fig. S2, panel B). When SignalP v3.0 was used to
predict presence of cleavage sites for bacterial signal peptidases, five
proteins commonly expressed in the supernatants at the mid-
logarithmic and stationary phase cultures (i.e., FabB, PlsC, Spr, FliD,
and Fiu) and four proteins that were newly-released detected at the
early-stationary phase of growth (i.e., BaeS, FlgK, AslA and three
isoforms of FliD) were predicted as secretory proteins of the classical
Sec pathway. The cell motility and secretion proteins, FliD and FlgK,
were predicted as secretory proteins, as expected. The TMHMM
v2.0 algorithm predicted the mid-logarithmic phase proteins, PlsC
and Spr, as integral membrane-associated proteins with one helix. In
addition, two newly-released proteins detected in the early-stationary
phase bacterial culture supernatant, i.e., BaeS and AslA, were also
identified as integral membrane-associated proteins, with two helices
and one helix, respectively.
Discussion
B. cepacia is known to adhere, invade, replicate, survive and
persist in the host cells, as well as evade the host immune response
Figure 1. Growth curve of Burkholderia cepacia and isocitrate dehydrogenase activity at the different phases of growth. The culture
was inoculated in LB medium and grown at 37uC from 0 h to 24 h. It was harvested at every 2 h intervals and the bacterial density was determined at
OD600 nm. An isocitrate dehydrogenase assay to specifically detect bacterial lysis in the culture supernatant was preformed. These experiments were
conducted in three independent replicates.
doi:10.1371/journal.pone.0026518.g001
Table 1. Mean percentage of invasion (%) with standard
deviation MOI 1:10 and1:50.
B. cepacia growth phase Invasion
MOI 1:10 MOI 1:50
Mid logarithmic 0.004460.0016 0.008960.0016
Early-stationary 0.008860.0032 0.015560.0016
doi:10.1371/journal.pone.0026518.t001
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[3]. Many studies have demonstrated the ability of B. cepacia to
invade and survive within epithelial cells in vitro [3,22–24]. In
addition, proteins secreted by this pathogen are of special interest
because they come in direct contact with the host tissues and may
mediate pathogenesis. Several studies have identified proteins
secreted by B. cepacia as the virulence factors involved in
pathogenesis [25,26]. The secretory proteins have also been
suggested as potential diagnostic biomarkers and/or candidates for
development of vaccine and therapeutic intervention [27].
In this study, B. cepacia harvested at mid-logarithmic and early-
stationary phases were tested for their ability to invade and
multiply inside epithelial cells within 3 hours of exposure. During
the mid-logarithmic phase, the bacterial cells are dividing actively
and the number of bacteria increased as the duration of growth
increased. In the early-stationary phase, the bacteria were still
dividing, but very slowly perhaps due to low carbon reserves in the
medium. The results suggest that the invasion efficiency of B.
cepacia was directly related to the phases of growth at which the
bacterial cells were harvested and used for the invasion studies.
The bacterial invasiveness at the early-stationary phase of growth
was greater than the mid- log phase in this in vitro condition.
Similarly, the increased number of bacteria inoculated also
resulted in the increase of invasive ability. Collectively, these
factors may contribute to the virulence potential of pathogenic B.
cepacia. The possible explanation of this could be due to the
secretion of different type of bacterial proteins or enzymes which
are known to play roles in colonisation or invasion by damaging
the epithelial cells. In addition, the secretory enzymes are also
known to damage the host cells and/or have direct effect of
facilitating the bacterial growth and cell to cell spreading. The
damage to the host is part of the pathology of infectious disease as
a result of bacterial invasive activity.
In addition, the supernatants of B. cepacia cultures obtained at
different time-points of growth were initially demonstrated to exert
cytotoxic effects on the mammalian A549 human lung epithelial
cells. The cytotoxic effects apparently increased with time,
suggesting that this might be due to the increasing amounts
and/or types of cytotoxic proteins that accumulated in the culture
supernatant during the growth cycle [28]. The variation in
cytotoxic potency of supernatants collected at the different growth
phases, particularly the mid-logarithmic and early-stationary
phases, suggests differences in the pathogenic potentials of B.
cepacia to infect and cause disease in man.
In an attempt to identify and predict the roles of the proteins in
the supernatants during the mid-logarithmic and early-stationary
phases of B. cepacia culture, a gel-based proteomics study was
performed. When separated by 2-DE at pH 4–7, 37 proteins were
identified and commonly mapped at both the mid-logarithmic and
early-stationary culture phases of the B. cepacia secretome. Aside
from these, 13 proteins were exclusively identified in the mid-
logarithmic phase and 40 proteins were newly-released in the
early-stationary phase. This was generally in slight variation with
our previous report [17] and that of others [27,29], but the
differences may be attributed to the variations in the time of
collection of the supernatants as well as the inherent genetic
differences in the strains used in the experiments [17]. When taken
Figure 2. The intracellular survival assay of B. cepacia (mid-logarithmic and early-stationary phases of growth) after 3 hours of post-
infection with MOI of 1:10 and 1:50 was as Log10 cfu/ml of the bacteria recovered. These experiments were conducted in three
independent replicates. The error bars indicate the standard deviation. The significance has been indicated using *.
doi:10.1371/journal.pone.0026518.g002
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together with the findings of the cytotoxicity experiments, the
differential protein profiles detected in the mid-logarithmic and
early-stationary growth phases of the B. cepacia secretome suggests
that the proteins may have contributed to the different cytotoxic
effects of the supernatants.
The in silico technologies such as PSORT and SignalP facilitated
prediction of cellular localisation and signal peptide of the B.
cepacia released proteins. Of the 46 identified protein spots released
at the mid-logarithmic phase, 50% were predicted to have
originated from the cytoplasm. This is similar to the reported
secretome proteins of B. cenocepacia H111 [29]. Analysis of the 46
identified proteins detected at the mid-logarithmic phase by COG
demonstrated that 52% were involved in metabolism, which is
similar to that reported in Shigella flexneri [30]. This was not
surprising as bacteria are known to actively multiply at this phase
of growth to increase its population number for host colonisation.
Many of the proteins synthesised during this phase would therefore
be involved in the metabolism of nutrients to sustain growth as
well as biogenesis of new cells. The active multiplication of
bacterial cells during this phase was also reflected by detection of
the cell division proteins, FtsZ and FtsA, in the supernatants
collected, which explains the increased in the number of bacteria
that invaded the host cells. Increase in both FtsZ and FtsA, which
was required to cause early central division of the cells, was also
earlier demonstrated in the Escherichia coli [31].
Among the six identified proteins that were exclusively released
at the mid-logarithmic growth phase, three were metabolic
proteins (i.e., purA, guaB and TpiA) while the remainder (i.e.,
RfaG, GlmU and DnaK) were involved in cellular processes.
These proteins may not be required during the early-stationary
phase, and thus, no longer secreted and degraded. DnaK, a
molecular chaperone used in protein folding [32], was present in
three isoforms in the B. cepacia mid-logarithmic phase secretome,
and all three isoforms were absent at the early-stationary phase of
growth. Presence of DnaK during the mid-logarithmic growth
phase could be attributed to its role in protein folding during
biogenesis of proteins in the dividing cells [32,33]. Its absence at
the early-stationary phase was most likely due to the lack of
biogenesis in cells that were not dividing. Unlike DnaK, the
60 kDa chaperonin, GroL, appeared to be released in both the
mid-logarithmic and early-stationary phases of bacterial growth.
The data of our present study demonstrated a considerable
number of proteins being continuously released by B. cepacia in
both the mid-logarithmic and early-stationary phases of growth.
This was most likely due to their constitutive secretion/release
and/or stability of the proteins which did not undergo denatur-
ation and many of these proteins were enzymes involved in
metabolism. Some of the secreted proteins are effector molecules
while others possess enzymatic activities for housekeeping purposes
which may also be associated with pathogenicity [26].
At the early-stationary phase of the bacterial culture, 40 of the
83 protein spots that were identified appeared to be newly-released
proteins. Six proteins, i.e., Eno, AlaDH, TktA, Fiu, FusA and
FliD, were resolved into their isoform subunits. Presence of the
isoforms was probably due to differences in post-translational
modifications, although very little is known on the role of post-
translational modifications in bacterial physiology [34]. The early-
stationary phase of growth is a state of stability where the bacteria
Figure 3. Effect of Burkholderia cepacia culture supernatant on A549, human lung epithelial cells. The cytotoxicity effect was determined
using MTT assay. The experiment was performed in triplicates with RPMI and LB media used as control. The error bars indicate the standard deviation.
The error bars indicate the standard deviation.
doi:10.1371/journal.pone.0026518.g003
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do not actively multiply. Therefore, the release of new proteins
into the supernatant was more likely to be involved in the
pathogenesis mechanism.
Aside from known secretory proteins, approximately 50% of the
proteins released into the supernatant at the early-stationary phase
of growth in this study were predicted to have originated from the
cytoplasm. As previously observed, some cytoplasmic proteins may
indeed be secreted into the environment during the different stages
of the cell cycle [35]. Among the proteins that were identified at
the early-stationary phase, 35% were found to be involved in
metabolic functions. The release of the metabolic enzymes at this
phase was possibly for energy conservation and bacterial survival
due to depletion of the limited carbon source in the growth
medium. On the other hand, metabolic proteins have also been
suggested to play a role in virulence [34], and their release at the
early-stationary phase may also be for the purpose of adherence
and/or invasion of the host cells.
Two of the proteins that were newly-released into the
supernatant during the early-stationary phase of the B. cepacia
culture, FliD and FlgK, were presumably generated during the
flagellum assembly or degradation. B. cepacia culture supernatant
flagellins were also identified as potential diagnostic candidates
Figure 4. Analysis of B. cepacia culture supernatant by 2-DE. The supernatant of B. cepacia grown to mid-logarithmic (panel A) and early-
stationary (panel B) phases in LB medium were prepared using TCA precipitation method and analysed using 2-DE. A total of 400 mg of culture
supernatant was separated on an IPG strip pH 4–7 in the first dimension, followed by the separation on SDS-12% PAGE for the second-dimension
separation. The separated proteins were detected by CBB G-250 staining. Marked spots indicate proteins that were identified. N refers to spots that
were not possibly identified by MALDI-TOF.
doi:10.1371/journal.pone.0026518.g004
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[27]. Relatively high amounts of flagellins have been previously
reported to be released by many Burkholderia species into their
culture supernatants [27,29,34]. The secretion of flagellins
improved motility, which is required for successful adherence
and colonisation at this stage of the growth cycle and as such this
finding is consistent with the increase of invasion efficiency
observed in this present study. Both of these proteins had also been
previously reported to be present in the B. cepacia early-stationary
phase culture supernatant by others [17,36].
Apart from the flagellins, FusA [33], Fiu [37], Pgk [38] AslA
[39] GroL [40] and GapA [41] are also proteins known to be
associated with virulence. The release of FliD, FlgK, FusA, Fiu,
Pgk and AslA into the culture supernatant of B. cepacia at the early-
stationary phase of growth provides some explanation for its
higher cytotoxic activity on the A549 cells compared to the
supernatant that was obtained at the mid-logarithmic phase.
Differences in the ability of B. cepacia to invade and survive
intracellularly inside the epithelial cells at different phases of
growth may also improve our understanding of the varied disease
progressions associated with B. cepacia infections. The virulent
proteins that were identified in the present study may used as
targets for the development of new strategies to control the B.
cepacia infection using agents that can block their secretion.
Supporting Information
Figure S1 Protein categories and the subcellular localisation of
identified Burkholderia cepacia culture at the mid-logarithmic phase.
Functional protein categories were predicted using COG, while
subcellular localisation was predicted using PSORT. Panels A and
B refer to protein functions and cellular location, respectively.
(TIF)
Figure S2 Protein categories and the subcellular localisation of
identified Burkholderia cepacia culture at the early stationary phase.
Functional protein categories and subcellular localisation were
predicted using COG and PSORT, respectively. Panel A refer to
protein functions and panel B refers to cellular location.
(TIF)
Table S1 Identification of Burkholderia cepacia culture supernatant
proteins using MALDI-TOF analysis.
(DOC)
Table S2 In silico analysis of Burkholderia cepacia culture
supernatant proteins.
(DOC)
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